Download Chi-yue Chiu Chinese University of Hong Kong Ying

Role of Cultural Diversity in Creativity and Innovation in Developing Economies: A Multilevel Perspective Chi‐yue Chiu
Chinese University of Hong Kong
Ying‐yi Hong
Nanyang Technological University
Presentations
• Can money buy high impact innovation?
Letty Yan Yee Kwan, Sun Yat‐Sen University
• Why are some countries more innovative than others?
Namrita Bendapudi, Nanyang Technological University
• How to harness multicultural experience to promote creativity Angela Ka‐Yee Leung, Singapore Management University
• Growing Identity Integration: Unlocking creativity and innovation in employees
Chi‐ying Cheng, Singapore Management University
• Enhancing performance of integrative research research
Shyhnan Liou, National Cheng‐Kung University
Problems the Panel Members Try to Solve
• Robert Solow: Half of the source of economic growth is attributable to technological innovation
– New capital: New capital is produced through technology and is assumed to be constantly improving
– New capital is more valuable than old capital in driving economic growth
• Lawrence Liu: The rise of China, high level of saving before 1980s, but the rapid post‐1980 economic growth in China results from increase in capital per work.
Question: Developing economies need to catch up with S&T, but how?
• Question: Can money buy S&T outcomes, particularly profound S&T outcomes?
• Answer: It depends; S&T investment is accompanied by S&T outcomes only when there is adequate institutional support for attracting and retaining global talents. • Question: Can cultural and functional diversity enhance creativity and innovation?
• Answer: It depends; the capacity to leverage on and manage diversity at individual and firm levels is of critical importance
DUNLAP-HINKLER ET AL., 2010,
SEJ:
Ｄata: 1699 new FDA’s (Food & Drug Administration) new applications from 98 firms
between 1992 to 2002.
Codings:
Breakthrough Innovations
Conceptual definition: innovations that start the cycle of technological change.
Operational definition: New molecular entities; New active ingredients that have never been
marketed before in any other form in the United States
Incremental innovations
Conceptual definition: innovations in the form of new features, extensions, variations, or
complements to an existing product line.
Operational definition: (1) new chemical types that have been marketed in the US before in
one form or another; (2) generics that are bioequivalent to previously approved new drug
applications
AN IMPORTANT MESSAGE
Products that emerged from joint ventures or alliances are
more likely to be breakthroughs. This result “highlights
the benefits associated with exploiting knowledge from
foreign centers of excellence.” (p. 106)
Foreign subsidiary participation in innovation processes
was not associated with the likelihood of breakthroughs.
Challenges: Boundary crossing and cultural clash